Amrutanjan Health Care Limited (BOM:590006)
India · Delayed Price · Currency is INR 506.25
-0.95 (-0.19%)
At close: Sep 4, 2026
Amrutanjan Health Care Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 5,115 | 5,026 | 4,518 | 4,212 | 3,796 | 4,058 |
Other Revenue | - | 2.04 | 1.47 | 1.41 | 1.23 | 1.06 |
| 5,115 | 5,028 | 4,520 | 4,214 | 3,798 | 4,059 | |
Revenue Growth | 10.68% | 11.24% | 7.26% | 10.96% | -6.45% | 21.90% |
Cost of Revenue | 2,493 | 2,498 | 2,289 | 2,170 | 1,874 | 1,838 |
Gross Profit | 2,622 | 2,530 | 2,230 | 2,043 | 1,924 | 2,221 |
Selling, General & Admin | 1,355 | 719.56 | 597.16 | 484.02 | 492.2 | 484.84 |
Other Operating Expenses | 628.91 | 1,116 | 1,035 | 1,026 | 960 | 879.76 |
Operating Expenses | 2,051 | 1,899 | 1,698 | 1,571 | 1,505 | 1,423 |
Operating Income | 571.42 | 630.37 | 532.59 | 472.47 | 418.55 | 798.41 |
Interest Expense | -1.87 | -1.95 | -2.19 | -1.57 | -0.77 | -4.85 |
Interest & Investment Income | - | 159.2 | 160.47 | 148.05 | 117.83 | 111.7 |
Currency Exchange Gain (Loss) | - | - | 0.26 | 0.62 | 2.38 | 1.25 |
Other Non Operating Income (Expenses) | 169.61 | 1.98 | 0.19 | 0.69 | 0.24 | 0.83 |
EBT Excluding Unusual Items | 739.16 | 789.6 | 691.32 | 620.26 | 538.23 | 907.34 |
Gain (Loss) on Sale of Investments | - | 0.76 | 0.02 | -1.26 | -2.05 | -1.57 |
Gain (Loss) on Sale of Assets | - | 1.04 | - | 1.57 | 0.27 | - |
Asset Writedown | - | - | - | -1.11 | - | - |
Other Unusual Items | -12.52 | -12.52 | - | - | - | - |
Pretax Income | 726.65 | 778.88 | 691.34 | 619.46 | 536.45 | 905.77 |
Income Tax Expense | 186.92 | 199.7 | 182.99 | 169.73 | 138.11 | 233.88 |
Earnings From Continuing Operations | 539.72 | 579.18 | 508.35 | 449.73 | 398.35 | 671.89 |
Net Income | 539.72 | 579.18 | 508.35 | 449.73 | 398.35 | 671.89 |
Net Income to Common | 539.72 | 579.18 | 508.35 | 449.73 | 398.35 | 671.89 |
Net Income Growth | -1.02% | 13.93% | 13.04% | 12.90% | -40.71% | 9.80% |
Shares Outstanding (Basic) | 29 | 29 | 29 | 29 | 29 | 29 |
Shares Outstanding (Diluted) | 29 | 29 | 29 | 29 | 29 | 29 |
Shares Change | -0.14% | - | -0.38% | -0.71% | -0.03% | 0.00% |
EPS (Basic) | 18.67 | 20.03 | 17.58 | 15.50 | 13.65 | 23.00 |
EPS (Diluted) | 18.67 | 20.03 | 17.58 | 15.50 | 13.63 | 22.98 |
EPS Growth | -0.89% | 13.94% | 13.44% | 13.70% | -40.69% | 9.79% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -190.36 | 153.46 | 211.93 | 112.54 | 287.32 |
Free Cash Flow Per Share | - | -6.58 | 5.31 | 7.30 | 3.85 | 9.83 |
Dividend Per Share | - | 4.900 | 4.600 | 4.600 | 4.600 | 4.600 |
Dividend Growth | - | 6.52% | 0% | 0% | 0% | 9.52% |
Gross Margin | 51.27% | 50.31% | 49.35% | 48.49% | 50.65% | 54.72% |
Operating Margin | 11.17% | 12.54% | 11.78% | 11.21% | 11.02% | 19.67% |
Profit Margin | 10.55% | 11.52% | 11.25% | 10.67% | 10.49% | 16.55% |
Free Cash Flow Margin | - | -3.79% | 3.40% | 5.03% | 2.96% | 7.08% |
EBITDA | 637.38 | 683.04 | 584.69 | 520.33 | 458.66 | 830.49 |
EBITDA Margin | 12.46% | 13.59% | 12.94% | 12.35% | 12.08% | 20.46% |
D&A For EBITDA | 65.96 | 52.67 | 52.1 | 47.86 | 40.11 | 32.09 |
EBIT | 571.42 | 630.37 | 532.59 | 472.47 | 418.55 | 798.41 |
EBIT Margin | 11.17% | 12.54% | 11.78% | 11.21% | 11.02% | 19.67% |
Effective Tax Rate | 25.72% | 25.64% | 26.47% | 27.40% | 25.74% | 25.82% |
Revenue as Reported | 5,284 | 5,201 | 4,695 | 4,376 | 3,942 | 4,212 |